dc.contributor.author |
Els, Fiona
|
|
dc.contributor.author |
Kleynhans, Jackie
|
|
dc.contributor.author |
Wolter, Nicole
|
|
dc.contributor.author |
Du Plessis, Mignon
|
|
dc.contributor.author |
Moosa, Fahima
|
|
dc.contributor.author |
Tempia, Stefano
|
|
dc.contributor.author |
Makhasi, Mvuyo
|
|
dc.contributor.author |
Nel, Jeremy
|
|
dc.contributor.author |
Dawood, Halima
|
|
dc.contributor.author |
Meiring, Susan
|
|
dc.contributor.author |
Von Gottberg, Anne
|
|
dc.contributor.author |
Cohen, Cheryl
|
|
dc.contributor.author |
Walaza, sibongile
|
|
dc.date.accessioned |
2024-11-27T04:43:42Z |
|
dc.date.available |
2024-11-27T04:43:42Z |
|
dc.date.issued |
2024-07-26 |
|
dc.description |
DATA AVAILABILITY : Data were generated at various facilities in the pneumonia
surveillance programme. Derived data supporting the
findings of this study are available from the corresponding
author, F.E. on request. |
en_US |
dc.description.abstract |
BACKGROUND : Comparisons of the characteristics of individuals hospitalised with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) or seasonal influenza in low-to middleincome
countries with high human immunodeficiency virus (HIV) prevalence are limited.
OBJECTIVES : Determine the epidemiological differences with those hospitalised with influenza
or SARS-CoV-2 infection.
METHOD : We investigated hospitalised individuals ≥18 years of age testing positive for seasonal
influenza (2016–2019) or SARS-CoV-2 (2020–2021). We used random effects multivariable
logistic regression, controlling for clustering by site, to evaluate differences among adults
hospitalised with influenza or SARS-CoV-2 infection.
RESULTS : Compared to individuals with influenza, individuals with SARS-CoV-2 infection
were more likely to be diabetic (adjusted odds ratio [aOR]: 1.70, 95% confidence interval [CI]:
1.11–2.61) or die in hospital (aOR: 2.57, 95% CI: 1.61–4.12). Additionally, those with SARSCoV-
2 infection were less likely to be living with HIV (not immunosuppressed) (aOR: 0.50,
95% CI: 0.34–0.73) or living with HIV (immunosuppressed) (aOR: 0.27, 95% CI: 0.18–0.39)
compared to not living with HIV and less likely to be asthmatic (aOR: 0.21, 95% CI: 0.13–0.33)
rather than those living with influenza.
CONCLUSION : Individuals hospitalised with SARS-CoV-2 had different characteristics to
individuals hospitalised with influenza before the coronavirus disease 2019 (COVID-19)
pandemic. Risk factors should be considered in health management especially as we move
into an era of co-circulation of SARS-CoV-2 and influenza pathogens.
CONTRIBUTION : Identifying groups at high risk of severe disease could help to better monitor,
prevent and control SARS-CoV-2 or influenza severe disease. |
en_US |
dc.description.department |
School of Health Systems and Public Health (SHSPH) |
en_US |
dc.description.librarian |
am2024 |
en_US |
dc.description.sdg |
SDG-03:Good heatlh and well-being |
en_US |
dc.description.sponsorship |
The Wellcome Trust; the CDC under the terms of a subcontract with the African Field Epidemiology Network (AFENET), the South African Medical Research Council (SAMRC); the African Society of Laboratory Medicine (ASLM) and Africa Centers for Disease Control and Prevention through a sub-award from the Bill and Melinda Gates Foundation; the National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa. |
en_US |
dc.description.uri |
http://www.sajid.co.za |
en_US |
dc.identifier.citation |
Els, F., Kleynhans, J., Wolter, N.. et al. Comparing adults with severe SARS-CoV-2 or influenza infection: South Africa, 2016–2021. Southern African Journal of Infectious Diseases 2024;39(1), a574. https://DOI.org/10.4102/sajid.v39i1.574. |
en_US |
dc.identifier.issn |
2312-0053 (print) |
|
dc.identifier.issn |
2313-1810 (online) |
|
dc.identifier.other |
10.4102/sajid.v39i1.574 |
|
dc.identifier.uri |
http://hdl.handle.net/2263/99420 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
AOSIS |
en_US |
dc.rights |
© 2024. The Authors. Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License. |
en_US |
dc.subject |
Pneumonia surveillance |
en_US |
dc.subject |
Risk factors |
en_US |
dc.subject |
Severe respiratory illness |
en_US |
dc.subject |
Pre-pandemic |
en_US |
dc.subject |
COVID-19 pandemic |
en_US |
dc.subject |
Coronavirus disease 2019 (COVID-19) |
en_US |
dc.subject |
Human immunodeficiency virus (HIV) |
en_US |
dc.subject |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
en_US |
dc.subject |
SDG-03: Good health and well-being |
en_US |
dc.title |
Comparing adults with severe SARS-CoV-2 or influenza infection : South Africa, 2016-2021 |
en_US |
dc.type |
Article |
en_US |